Yoshikazu Nishimura
5PUBLICATIONS
4CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Jan 26, 2024
Synthesis and Biological Evaluations of Novel Human Parathyroid Hormone 1 Receptor (hPTHR1) Agonists Bearing Bicyclic Aromatic Moiety.Yoshikazu Nishimura, Toru Esaki, Yoshiaki Isshiki
|Oct 24, 2023
Validation of a New Methodology to Create Oral Drugs beyond the Rule of 5 for Intracellular Tough Targets.Atsushi Ohta, Mikimasa Tanada, Shojiro Shinohara
|Jul 18, 2023
Development of Orally Bioavailable Peptides Targeting an Intracellular Protein: From a Hit to a Clinical KRAS Inhibitor.Mikimasa Tanada, Minoru Tamiya, Atsushi Matsuo
|Feb 06, 2020
Lead Optimization and Avoidance of Reactive Metabolite Leading to PCO371, a Potent, Selective, and Orally Available Human Parathyroid Hormone Receptor 1 (hPTHR1) Agonist.Yoshikazu Nishimura, Toru Esaki, Yoshiaki Isshiki
|Jun 23, 2018
Development of a Novel Human Parathyroid Hormone Receptor 1 (hPTHR1) Agonist (CH5447240), a Potent and Orally Available Small Molecule for Treatment of Hypoparathyroidism.Yoshikazu Nishimura, Toru Esaki, Yoshiaki Isshiki
Pageof 1
